Handbook of Clinical medicine

in a person with HIV is given in table 9.11. This is not exhaustive. Do not forget your usual diff erentials, the presen- tation may not relate to the patient’s HIV status. Opportunistic disease ART is part of the treatment regimen of all opportunistic infections (see pp402–3). • Pneumocystis jirovecii: (‘yee-row-vet-zee’) Presentation: progressive SOB on exertion, malaise, dry cough. Haemoptysis and pleuritic pain rare. Examination: respiratory rate, often normal breath sounds. Investigation: SpO 2 (compare rest and exertion). CXR: classically perihilar infi ltrates (fi g 9.12), but may be normal. In- duced sputum or BAL with staining or nucleic acid amplifi cation. Treatment: IV co-trimoxazole (convert to oral if favourable response). 21-day course. Steroids in moderate–severe disease (PO<9.3KPa/SpO<92%). 2nd-line: clindamycin, penta- a 2 2 midine, atovaquone. Prophylaxis: co-trimoxazole if CD4 <200 cells/microlitre. • Candidiasis: Oral or oesophageal. Pain in the tongue, dysphagia, odynophagia. Di- agnosed clinically or endoscopically. Treated with systemic ‘-azole’, eg fl uconazole. • Cryptococcus neoformans: Commonest systemic fungal infection in HIV (5–10% pre-ART). Presentation: meningitis: headache, fever, meningism variable. May be associated skin (molluscum-like papules) and lung disease. Investigation: LP with manometry. CSF stain (India ink), CSF/blood cryptococcal antigen. Treatment: in- duction with liposomal amphotericin B (SE:
